Advanced search
Publication Cover
International Reviews of Immunology Volume 25, 2006 - Issue 5-6
Submit an article Journal homepage
83
Views
12
CrossRef citations to date
0
Altmetric
Original

Promises and Limitations of Murine Models in the Development of Anticancer T-Cell Vaccines

Frédéric Lévy Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, SwitzerlandCorrespondence[email protected]
&
Sara Colombetti Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland
Pages 269-295 | Published online: 03 Aug 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mohan Karkada, Neil L Berinstein & Marc Mansour. (2014) Therapeutic vaccines and cancer: focus on DPX-0907. Biologics: Targets and Therapy 8, pages 27-38.
Read now
Vincent G Brichard & Diane Lejeune. (2008) Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease. Expert Opinion on Biological Therapy 8:7, pages 951-968.
Read now

Articles from other publishers (10)

Shernan G Holtan, Roxana S Dronca, Wendy K Nevala, Luis F Porrata, Aaron S Mansfield, Matthew S Block, Alexey A Leontovich, Travis E Grotz, James D Turner, Harold P Frisch & Svetomir N Markovic. (2011) The dynamic human immune response to cancer: it might just be rocket science. Immunotherapy 3:9, pages 1021-1024.
Crossref
Matthew S. Block, Wendy K. Nevala, Alexey A. Leontovich & Svetomir N. Markovic. (2011) Differential Response of Human and Mouse Dendritic Cells to VEGF Determines Interspecies Discrepancies in Tumor-Mediated Th1/Th2 Polarity Shift. Clinical Cancer Research 17:7, pages 1776-1783.
Crossref
Zhao Sun, Wei Wang, Rui Wang, Jinhong Duan, Yan Hu, Jin Ma, Jiayan Zhou, Sishen Xie, Xin Lu, Zhaohui Zhu, Shuchang Chen, Yuanli Zhao, Haiyan Xu, Chen Wang & Xian-Da Yang. (2010) Aluminum nanoparticles enhance anticancer immune response induced by tumor cell vaccine. Cancer Nanotechnology 1:1-6, pages 63-69.
Crossref
Mohan Karkada, Genevieve M. Weir, Tara Quinton, Leeladhar Sammatur, Lisa D. MacDonald, Alecia Grant, Robert Liwski, Ridas Juskevicius, Gomathinayagam Sinnathamby, Ramila Philip & Marc Mansour. (2010) A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses. Journal of Immunotherapy 33:3, pages 250-261.
Crossref
Nir Peled, Ana B Oton, Fred R Hirsch & Paul Bunn. (2009) MAGE A3 antigen-specific cancer immunotherapeutic. Immunotherapy 1:1, pages 19-25.
Crossref
Jie Meng, Jie Meng, Jinhong Duan, Hua Kong, Li Li, Chen Wang, Sishen Xie, Shuchang Chen, Ning Gu, Haiyan Xu & Xian-Da Yang. (2008) Carbon Nanotubes Conjugated to Tumor Lysate Protein Enhance the Efficacy of an Antitumor Immunotherapy. Small 4:9, pages 1364-1370.
Crossref
Hidemasa Tamai, Satoshi Watanabe, Rongxiu Zheng, Katsuya Deguchi, Peter A. Cohen, Gary K. Koski & Suyu Shu. (2008) Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic–tumor hybrid vaccination and adoptive transfer of sensitized T cells. Clinical Immunology 127:1, pages 66-77.
Crossref
Daniel L. Levey. 2008. Cancer Vaccines: Challenges and Opportunities in Translation. Cancer Vaccines: Challenges and Opportunities in Translation 31 54 .
Trina J. Stewart & Scott I. Abrams. (2007) Altered Immune Function during Long-Term Host-Tumor Interactions Can Be Modulated to Retard Autochthonous Neoplastic Growth. The Journal of Immunology 179:5, pages 2851-2859.
Crossref
Vincent G. Brichard & Diane Lejeune. (2007) GSK's antigen-specific cancer immunotherapy programme: Pilot results leading to Phase III clinical development. Vaccine 25, pages B61-B71.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.